BIOMARIN PHARMACEUTICAL INC Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Biomarin Pharmaceutical Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $114M, a 273% increase year-over-year.
  • Biomarin Pharmaceutical Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $322M, a 141% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2023 was $158M, a 5.71% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2022 was $150M.
  • Biomarin Pharmaceutical Inc annual Operating Income (Loss) for 2021 was -$82.3M, a 89.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $322M $114M +$83.4M +273% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $239M $120M +$54.9M +83.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $184M $88.5M +$26.1M +41.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $158M -$398K +$24.1M +98.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $134M $30.5M +$32.9M Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $101M $65.6M +$26.4M +67.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $74.6M $62.4M -$74.9M -54.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $150M -$24.5M +$41.4M +62.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $108M -$2.42M +$50.8M +95.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $57.4M $39.2M +$27.5M +235% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $29.9M $137M +$112M +447% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 -$82.3M -$65.9M -$14.4M -27.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$68M -$53.2M +$2.72M +4.87% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 -$70.7M $11.7M +$52.6M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$123M $25.1M -$79.9M -76.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 -$43.4M -$51.5M -$42.4M -462% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$1.09M -$55.9M -$60M -1495% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $58.9M -$40.9M +$409K +0.99% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $58.5M $105M +$159M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 -$100M -$9.16M +$29M +76% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$129M $4.01M +$19.8M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$149M -$41.4M -$16.1M -63.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$133M -$54M -$9.58M -21.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 -$124M -$38.1M -$96.2M -166% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$27.3M -$15.7M -$2.01M -14.7% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 -$25.3M -$25.3M +$13.5M +34.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$38.9M -$44.4M -$24.2M -120% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 -$14.7M $58M +$148M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$162M -$13.7M +$46.4M +77.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 -$209M -$38.8M +$534M +93.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$743M -$20.2M +$60.7M +75% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 -$803M -$89.6M -$191M -188% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$612M -$60.1M +$21.8M +26.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$634M -$573M -$509M -791% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$126M -$80.9M -$15.1M -22.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$111M $101M +$160M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 -$271M -$81.9M -$93.1M -831% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$178M -$64.3M -$45.4M -240% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$132M -$65.9M -$39.4M -149% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$92.9M -$58.8M -$6.45M -12.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$86.4M $11.2M +$61.9M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 -$148M -$18.9M +$1.17M +5.84% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$150M -$26.5M +$6.47M +19.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$156M -$52.3M -$5.41M -11.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$151M -$50.7M -$40.2M -384% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 -$110M -$20.1M +$10.9M +35.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$121M -$32.9M -$11.1M -50.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 -$110M -$46.9M -$25.5M -119% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$84.7M -$10.5M +$5.03M +32.4% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 -$89.8M -$31M -$31.7M -4130% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 -$58.1M -$21.9M -$24.2M -1053% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 -$33.9M -$21.4M -$18.1M -540% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 -$15.8M -$15.5M -$13.6M -700% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 -$2.23M $768K -$2.28M -74.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $48K $2.29M -$496K -17.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q4 2010 $544K -$3.35M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-26
Q3 2010 -$1.94M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $3.04M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
Q1 2010 $2.79M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.